The RH5.1/Matrix-M blood-stage malaria vaccine shows promise as a crucial secondary defence against malaria, complementing ...

Advances in malaria research and control strategies bring hope for more effective treatments and the eventual elimination of ...

Scientists have engineered the pests to provide enhanced immunity to the disease they transmit, according to new study.

M shows promise with 55 effectiveness in trials Learn how this breakthrough could revolutionize malaria prevention ...

Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than ...

An initially "unknown" illness affecting hundreds in the Democratic Republic of the Congo may be attributable to malaria, ...

Chromatin is a combination of DNA and proteins that makes up the chromosomes in the cells of humans and other higher ...

Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.

These findings shed light on how T. gondii mitoribosome is assembled, providing insights into its distinctive biology and presenting potential new avenues for targeting the energy centers of these ...

While malaria remains a major public health challenge, its impact extends far beyond the immediate illness and death it ...

While malaria remains a major public health challenge, its impact extends far beyond the immediate illness and death it ...

Further, the vaccine demonstrated over 80 per cent efficacy against high levels of malaria parasites, which indicates the ...